Forward Earnings Estimate on Puma Biotechnology Inc(PBYI) – Money Flow Index & Trends

Puma Biotechnology Inc(PBYI) Indepth Earnings, EPS and Estimated Revenue Guidance give detailed picture on the performance.Puma Biotechnology Inc has received $-1.92 as the consensus Earnings Estimate for the Quarter ending on Mar 2017 ,According to the estimate provided by 3 Financial Advisor in the Stock Trading Firms. Among 3 Analysts, Bottom line EPS Estimate for the current quarter is $-2.48 while the top line estimate is $-1.2 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at 12.33%. Puma Biotechnology Inc results fell short with a surprise EPS of -1% or $-0.02. The Actual EPS was $-2.02 compared to the Estimated EPS of $-2 during its most recent quarterly earnings.

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Puma Biotechnology Inc was Reiterated by RBC Capital Mkts on Mar 2, 2017 to Sector Perform, Lowers Price Target to $ 17 from a previous price target of $48 .

Company has reported several Insider transactions to the SEC, on Jan 24, 2017, Steven Lo (Chief Commercial Officer) sold 2,290 shares at 33.24 per share price.On Jan 24, 2017, Charles R Eyler (officer ) sold 820 shares at 33.24 per share price.On Jan 24, 2017, Richard Paul Bryce (SR VP, CLINICAL RESEARCH & DEV) sold 2,293 shares at 33.24 per share price.

Based on Puma Biotechnology Inc filings, last years Annual Earnings was, $-8.29. In the last quarter, Puma Biotechnology Inc reported Annual Earnings of $-2.04. In the last Quarter, PBYI reported a surprise Earnings per Share of -0.99% . The consensus estimate for current quarter is $-1.92 and for the current fiscal year, the estimate is $-8.92. For the Next fiscal year, the estimate is $-4.44 based on the consensus.

Puma Biotechnology Inc (NYSE:PBYI) stock ended Thursday session in the red zone in a volatile trading. The stock closed down 1.05 points or 2.61% at $39.25 with 867,875 shares getting traded. Post opening the session at $40.3, the shares hit an intraday low of $38.5 and an intraday high of $40.45 and the price was in this range throughout the day. The company has a market cap of $1,450 million and the number of outstanding shares has been calculated to be 36,951,978 shares. The 52-week high of Puma Biotechnology Inc (NYSE:PBYI) is $73.27 and the 52-week low is $19.74.

Read the original here:
Forward Earnings Estimate on Puma Biotechnology Inc(PBYI) - Money Flow Index & Trends